Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Bouleau, Sylvina; 1 | Tricoire, Hervé; *
Affiliations: Unité de Biologie Fonctionnelle et Adaptative (BFA), UMR8251 CNRS-Univ Paris Diderot, Sorbonne Paris Cité, Paris, France
Correspondence: [*] Correspondence to: Hervé Tricoire, Unité de Biologie Fonctionnelle et Adaptative (BFA), Université Paris Diderot-CNRS UMR8251, 4 rue Marie Andrée Lagroua Weill Halle, 75205 PARIS CEDEX 13, France. Tel.: +33 1 1 57 27 79 51; Fax: +33 1 1 57 27 83 29; E-mail: herve.tricoire@univ-paris-diderot.fr.
Note: [1] Present address: Laboratoire de Génétique et Biologie Cellulaire, EA4589 Université de Versailles St Quentin en Yvelines, Ecole Pratique des Hautes Etudes, UFR des Sciences de la Santé Simone Veil, Montigny-Le-Bretonneux, France.
Abstract: Amyloid-β protein precursor (AβPP) and the microtubule-associated protein tau (MAPT) are the two key players involved in Alzheimer's disease (AD) and are associated with amyloid plaques and neurofibrillary tangles respectively, two key hallmarks of the disease. Besides vertebrate models, Drosophila models have been widely used to understand the complex events leading to AD in relation to aging. Drosophila benefits from the low redundancy of the genome which greatly simplifies the analysis of single gene disruption, sophisticated molecular genetic tools, and reduced cost compared to mammals. The aim of this review is to describe the recent advances in modeling AD using fly and to emphasize some limits of these models. Genetic studies in Drosophila have revealed some key aspects of the normal function of Appl and Tau, the fly homologues of AβPP and MAPT that may be disrupted during AD. Drosophila models have also been useful to uncover or validate several pathological pathways or susceptibility genes, and have been readily implemented in drug screening pipelines. We discuss some limitations of the current models that may arise from differences in structure of Appl and Tau compared to their human counterparts or from missing AβPP or MAPT protein interactors in flies. The advent of new genome modification technologies should allow the development of more realistic fly models and to better understand the relationship between AD and aging, taking advantage of the fly's short lifespan.
Keywords: Aging, Alzheimer's disease, amyloid beta-peptides, amyloid beta-protein precursor, disease models, Drosophila, nerve degeneration, tau proteins, tauopathy
DOI: 10.3233/JAD-142802
Journal: Journal of Alzheimer's Disease, vol. 45, no. 4, pp. 1015-1038, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl